The effect of STAT1 loss is also not restricted to tumors that display a particular pattern of expression of the estrogen receptor (ER): 7/13 of the spontaneously evolving Stat1−/− mammary cancers were ER+, while the remaining cases did not express detectable levels of the ER protein. The gene discussed is STAT1; the disease is breast cancer.